ARTICLE | Clinical News
Meridia sibutramine regulatory update
August 22, 2005 7:00 AM UTC
FDA rejected a Public Citizen petition to ban weight-loss drug Meridia because the agency believed that the overall risk-benefit profile supports keeping the drug available to obese patients. Public C...